Invesco
NUVB icon

Invesco’s Nuvation Bio NUVB Stock Holding History

Invesco’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Sell
437,806
-747,337
-63% -$4.16M ﹤0.01% 2574
2025
Q4 		$10.6M Buy
1,185,143
+687,597
+138% +$4.26M ﹤0.01% 1807
2025
Q3 		$1.84M Buy
497,546
+104,132
+26% +$284K ﹤0.01% 2647
2025
Q2 		$767K Buy
393,414
+25,642
+7% +$53.4K ﹤0.01% 2964
2025
Q1 		$647K Buy
367,772
+37,384
+11% +$85.1K ﹤0.01% 3047
2024
Q4 		$879K Buy
330,388
+7,344
+2% +$18.9K ﹤0.01% 2968
2024
Q3 		$740K Sell
323,044
-2,164
-0.7% -$6.6K ﹤0.01% 3049
2024
Q2 		$950K Buy
325,208
+3,194
+1% +$9.75K ﹤0.01% 2957
2024
Q1 		$1.17M Buy
322,014
+88,892
+38% +$171K ﹤0.01% 2917
2023
Q4 		$352K Buy
233,122
+11,337
+5% +$14.6K ﹤0.01% 3380
2023
Q3 		$297K Buy
221,785
+3,980
+2% +$6.62K ﹤0.01% 3463
2023
Q2 		$392K Sell
217,805
-1,612
-0.7% -$2.74K ﹤0.01% 3376
2023
Q1 		$364K Buy
219,417
+170,142
+345% +$345K ﹤0.01% 3432
2022
Q4 		$94.6K Buy
49,275
+130
+0.3% +$263 ﹤0.01% 3836
2022
Q3 		$110K Sell
49,145
-132
-0.3% -$377 ﹤0.01% 3820
2022
Q2 		$159K Sell
49,277
-12,422
-20% -$54.2K ﹤0.01% 3791
2022
Q1 		$325K Sell
61,699
-946
-2% -$5.32K ﹤0.01% 3599
2021
Q4 		$533K Buy
62,645
+29,225
+87% +$269K ﹤0.01% 3364
2021
Q3 		$332K Buy
33,420
+13,072
+64% +$118K ﹤0.01% 3613
2021
Q2 		$189K Buy
+20,348
New +$232K ﹤0.01% 3801

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco's NUVB Position: Q1 2026 in Review

Invesco reduced its Nuvation Bio (NUVB) stake by 63% in Q1 2026, selling an estimated $4.16M and leaving 437,806 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

Invesco first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. The position peaked at $10.6M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Invesco held 437,806 shares of Nuvation Bio worth $1.88M as of Q1 2026.
  • Invesco sold 747,337 Nuvation Bio shares in Q1 2026, an estimated $4.16M.
  • Nuvation Bio made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2574 holding.
  • Invesco first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
  • Invesco's Nuvation Bio position peaked at $10.6M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.